CombiMatrix gets more funding

July 1, 2003 – Newport Beach, CA – CombiMatrix, an operating group of Acadia Research Corporation, says it has received $5.8 million from its strategic partners in the second quarter. The company is developing technology to produce customizable active biochips, which are semiconductor-based tools for identifying and determining the roles of genes, gene mutations, and proteins.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.